If you’re wondering why J.J. McCarthy isn’t playing, check the calendar

Anyone shocked that J.J. McCarthy still hasn't returned from the high ankle sprain that he suffered in Week 2 needs to do ...
Zacks Investment Research on MSN

Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?

Johnson & Johnson JNJ delivered strong third-quarter 2025 results, with both the top and bottom lines exceeding expectations. Total revenues rose 6.8% to $24 billion, while adjusted EPS of $2.77 per ...